Tau depletion in human neurons mitigates Aβ-driven toxicity
Molecular Psychiatry · 2024-07 · 29 (7) · 2009-2020
DOI: 10.1038/s41380-024-02463-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Psychiatry, online erschienen am 15.02.2024. Verfasst von Bryan Ng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK. Hauptthemen laut MEDLINE: tau Proteins, Induced Pluripotent Stem Cells, Amyloid beta-Peptides, Neurons. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Parkinson's UK, Agency for Science, Technology and Research (A*STAR).
Abstract (Originalsprache)
Alzheimer’s disease (AD) is an age-related neurodegenerative condition and the most common type of dementia, characterised by pathological accumulation of extracellular plaques and intracellular neurofibrillary tangles that mainly consist of amyloid-β (Aβ) and hyperphosphorylated tau aggregates, respectively. Previous studies in mouse models with a targeted knock-out of the microtubule-associated protein tau (Mapt) gene demonstrated that Aβ-driven toxicity is tau-dependent. However, human cellular models with chronic tau lowering remain unexplored. In this study, we generated stable tau-depleted human induced pluripotent stem cell (iPSC) isogenic panels from two healthy individuals using CRISPR-Cas9 technology. We then differentiated these iPSCs into cortical neurons in vitro in co-culture with primary rat cortical astrocytes before conducting electrophysiological and imaging experiments for a wide range of disease-relevant phenotypes. Both AD brain derived and recombinant Aβ were used in this study to elicit toxic responses from the iPSC-derived cortical neurons. We showed that tau depletion in human iPSC-derived cortical neurons caused considerable reductions in neuronal activity without affecting synaptic density. We also observed neurite outgrowth impairments in two of the tau-depleted lines used. Finally, tau depletion protected neurons from adverse effects by mitigating the impact of exogenous Aβ-induced hyperactivity, deficits in retrograde axonal transport of mitochondria, and neurodegeneration. Our study established stable human iPSC isogenic panels with chronic tau depletion from two healthy individuals. Cortical neurons derived from these iPSC lines showed that tau is essential in Aβ-driven hyperactivity, axonal transport deficits, and neurodegeneration, consistent with studies conducted in Mapt−/− mouse models. These findings highlight the protective effects of chronic tau lowering strategies in AD pathogenesis and reinforce the potential in clinical settings. The tau-depleted human iPSC models can now be applied at scale to investigate the involvement of tau in disease-relevant pathways and cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
- Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
- James and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, OX1 3RE, Oxford, UK.
- JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, OX3 7BN, UK.
- Target Discovery Institute, Centres for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, NDM Research Building, Old Road Campus, Oxford, OX3 7FZ, UK.
- Oxford Drug Discovery Institute, Target Discovery Institute, University of Oxford, NDM Research Building, Old Road Campus, Oxford, OX3 7FZ, UK.
ORCID-Profile: Bryan Ng, Féodora Bertherat, Ajantha Abey, Darragh P O'Brien, Sally A Cowley
Förderung
- Medical Research Council
- Parkinson's UK
- Agency for Science, Technology and Research (A*STAR)
- RCUK | Medical Research Council (MRC)
- Oxford University | Oxford Martin School, University of Oxford
- Parkinson's UK
Zitieren
APA
Ng, B., Vowles, J., Bertherat, F., Abey, A., Kilfeather, P., Beccano-Kelly, D., Stefana, M. I., O'Brien, D. P., Bengoa-Vergniory, N., Carling, P. J., Todd, J. A., Caffrey, T. M., Connor-Robson, N., Cowley, S. A., & Wade-Martins, R. (2024). Tau depletion in human neurons mitigates Aβ-driven toxicity. Molecular Psychiatry, 29(7), 2009-2020. https://doi.org/10.1038/s41380-024-02463-2
Vancouver
Ng B, Vowles J, Bertherat F, Abey A, Kilfeather P, Beccano-Kelly D, et al. Tau depletion in human neurons mitigates Aβ-driven toxicity. Molecular Psychiatry. 2024;29(7):2009-2020. doi:10.1038/s41380-024-02463-2
BibTeX
@article{Ng2024,
author = {Ng, Bryan and Vowles, Jane and Bertherat, Féodora and Abey, Ajantha and Kilfeather, Peter and Beccano-Kelly, Dayne and Stefana, M Irina and O'Brien, Darragh P and Bengoa-Vergniory, Nora and Carling, Phillippa J and Todd, John A and Caffrey, Tara M and Connor-Robson, Natalie and Cowley, Sally A and Wade-Martins, Richard},
title = {Tau depletion in human neurons mitigates Aβ-driven toxicity},
journal = {Molecular Psychiatry},
year = {2024},
volume = {29},
number = {7},
pages = {2009--2020},
doi = {10.1038/s41380-024-02463-2}
}
EUVIMED